Artemis Healing Center Expands Teen Mental Health Programs in Arizona
June 11, 2025 — Artemis Adolescent Healing Center in Arizona expands teen mental health programs, offering personalized care and accepting insurance for accessible treatment.
Curated Health Wellness News
NewsRamp provides syndicated and curated news distribution and marketing services for major newswires.
HIGHER Corporation Recognized as 'Baby Unicorn' and 'First Penguin' for Global Potential
June 11, 2025 — HIGHER Corporation gains 'Baby Unicorn' and 'First Penguin' titles, highlighting its innovative HILO WAVE® technology and global market expansion in aesthetic medical devices.
Creative Biolabs Launches Advanced Platform for Microbiome Drug Development
June 11, 2025 — Creative Biolabs introduces an advanced microbial service platform to streamline microbiome-based drug development, offering standardized analytical frameworks for safety and efficacy.
Lifordi's LFD-200 ADC Shows Promise in Treating Autoimmune Disorders
June 11, 2025 — Lifordi Immunotherapeutics presents LFD-200 ADC data showing targeted treatment for autoimmune diseases without systemic toxicity, a potential game-changer in biotech.
VERAXA Biotech AG and Voyager Acquisition Corp. Merge in $1.64B Deal
June 10, 2025 — VERAXA Biotech AG merges with Voyager Acquisition Corp. in a $1.64B deal, advancing cancer therapy innovations and listing on NASDAQ as "VERX".
Calidi Biotherapeutics Appoints Eric Poma, PhD, as New CEO
June 10, 2025 — Calidi Biotherapeutics names Eric Poma, PhD, as CEO to lead innovative cancer therapy development. A leap forward in oncology treatment.
Medicus Pharma Ltd. Poised for Growth in $5 Trillion Biotech Market
June 10, 2025 — Medicus Pharma Ltd. (MDCX) is strategically expanding in the booming biotech sector, focusing on innovative treatments for human and veterinary medicine, with a $5 trillion market potential.
ONAR Appoints Healthcare Veteran Howard Palefsky to Board
June 10, 2025 — ONAR (OTCQB: ONAR) appoints Howard Palefsky to its Board, enhancing its healthcare marketing capabilities. Discover how this move fuels growth.
Young Celebrities Highlight Rising Breast Cancer Rates Among Women Under 50
June 10, 2025 — Young celebrities' breast cancer diagnoses spotlight rising cases in women under 50, urging action and innovation in treatment. BioMedWire amplifies critical health updates.
PayMedix & HPS Partner with Gravie to Revolutionize Healthcare Benefits
June 10, 2025 — PayMedix & HPS partner with Gravie to expand healthcare access and simplify payments, offering interest-free financing and a vast provider network for small businesses.
Oragenics to Showcase Concussion Treatment at Major Biotech Events
June 10, 2025 — Oragenics to present ONP-002, a novel concussion treatment, at 2025 BIO International Convention and National Neurotrauma Society Symposium, showcasing advancements in neurology.
Tonix Pharmaceuticals to Showcase Innovations at 2025 BIO Convention
June 10, 2025 — Tonix Pharmaceuticals to present at 2025 BIO Convention, showcasing TNX-102 SL for fibromyalgia and TNX-4200 antiviral, highlighting innovation in pain and public health solutions.
GeoVax Unveils Promising COVID-19 Vaccine Data for Immunocompromised at EHA2025
June 10, 2025 — GeoVax Labs presents GEO-CM04S1 vaccine data at EHA2025, showing promise for immunocompromised patients with superior immune response vs. mRNA vaccines.
Glucotrack Innovates Diabetes Care with Implantable Glucose Monitor
June 10, 2025 — Glucotrack Inc. introduces a revolutionary implantable CBGM system, addressing key diabetes management challenges with patient-focused innovation and promising clinical results.
Understanding Confined Spaces: Risks, Rescue Teams, and Regulations
June 10, 2025 — Explore the dangers of confined spaces, the critical role of rescue teams, and OSHA standards to ensure workplace safety and compliance.
Dr. Horowitz Demands Probe into COVID-19 Origins and Vaccine Tech
June 10, 2025 — Dr. Leonard Horowitz calls for investigation into COVID-19 origins and vaccine technologies, urging transparency and accountability in public health responses.
Alfa Cytology Pioneers Personalized Cancer Treatment with PARP Inhibitors
June 10, 2025 — Alfa Cytology introduces PARP inhibitors development services, revolutionizing personalized cancer treatment with advanced biotech solutions.
Ingrained Recovery Expands Equine Therapy Access with More Insurance Options
June 10, 2025 — Ingrained Recovery enhances Equine Therapy program, now accepting GEHA, TRICARE, and GHI insurance, making holistic treatment more accessible.
Tevard Biosciences Appoints Dr. Elisabeth Gardiner as CSO to Advance tRNA Therapies
June 10, 2025 — Tevard Biosciences names Dr. Elisabeth Gardiner as CSO to lead tRNA-based therapies for genetic diseases, marking a leap towards curing rare genetic disorders.
Pacylex to Showcase Breakthrough Cancer Therapies at BIO Convention
June 10, 2025 — Pacylex Pharmaceuticals to present groundbreaking NMT inhibitors for cancer at BIO Convention, offering new hope for hematologic and solid tumor treatments.